Nexstim Plc: Managers’ Transactions, Laine
Company Announcement, Helsinki, 22 May 2023 at 10:40 AM(EEST)
Nexstim Plc: Managers’ Transactions, Laine
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as follows:
Person subject to the notification requirement
Name: Jarmo Laine
Position: Other senior manager
Issuer: Nexstim Oyj
LEI: 743700S7ZI0LNMHZ6Y27
Notification type: INITIAL NOTIFICATION
Reference number: 32081/5/6
____________________________________________
Transaction date: 2023-05-17
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2023A
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 15796 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 15796 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2023-05-17
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2023B
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 15550 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 15550 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2023-05-17
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: 2023C
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 15303 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 15303 Volume weighted average price: 0 EUR
Further information is available on the website www.nexstim.com, or by contacting:
Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com
The Company’s Certified Advisor is Erik Penser Bank.
About Nexstim Plc
Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim’s Therapy Business markets and sells the Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.
Nexstim shares are listed on Nasdaq First North Growth Market Finland.
For more information, please visit www.nexstim.com
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report30.4.2024 23:30:00 CEST | Press release
Stockholm, 30 April 2024 - Anoto Group AB (publ) (“Anoto”) today publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report published on 29 February 2024. The annual report is available on the Company’s website, www.anoto.com. Compared to previously communicated results in the year-end report for 2023, Anoto reports a change in the results in the annual report. The corrections on the consolidated results stemmed from updates made to the Group’s impairment testing and financial forecasts, and relate to write-downs of goodwill, capitalized costs, and investment in Knowledge AI Inc., a former subsidiary and currently associated company of Anoto. The Group has written down 59.3 MSEK of goodwill in Livescribe Inc., and fully impaired its remaining goodwill in Anoto Korea – 37.6 MSEK. In addition, the Group has fully impaired its remaining fair value investment of 38.4 MSEK in Knowledge AI Inc. and 13.6 MSEK of its loan receivables. Finall
Anoto publicerar sin årsredovisning för 2023 och korrigerar för förändringar i resultatet som redovisats i bokslutskommunikén30.4.2024 23:30:00 CEST | Pressemelding
Stockholm den 30 april 2024 - Anoto Group AB (publ) (”Anoto”) publicerar idag sin årsredovisning för 2023 och korrigerar för förändringar i resultatet som redovisats i bokslutskommunikén som publicerades den 29 februari 2024. Årsredovisningen finns tillgänglig på bolagets hemsida, www.anoto.com. Jämfört med tidigare kommunicerade resultat i bokslutskommunikén för 2023 redovisar Anoto en förändring av resultatet i årsredovisningen. Korrigeringarna av koncernens resultat är föranledda av uppdateringar gjorda i samband med koncernens nedskrivningsprövning och finansiella prognoser, och avser nedskrivningar av goodwill, aktiverade kostnader och investeringar i Knowledge AI Inc., ett tidigare dotterbolag och för närvarande ett intressebolag till Anoto. Koncernen har skrivit ned 59,3 MSEK av goodwill i Livescribe Inc., och helt skrivit ned återstående goodwill i Anoto Korea med 37,6 MSEK. Dessutom har koncernen helt skrivit ned sin återstående investering på 38,4 MSEK i Knowledge AI Inc. och
Completion of Second Tranche of Tenaris Share Buyback Program. Weekly Report (Monday, April 29, 2024)30.4.2024 23:11:34 CEST | Press release
LUXEMBOURG, April 30, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) announced today the completion of the second tranche of its previously announced Share Buyback Program. During the second tranche, which ran from February 26, 2024, to (and including) April 29, 2024, the Company purchased a total of 16,367,003 ordinary shares for a total consideration of €277,137,521, or US$300 million. On April 29, 2024, the Company purchased the following ordinary shares: DateTrading VenueShares PurchasedWeighted Average Price (EUR)Purchases in EURReference FXPurchases in USD29-apr-24MTA576,15515.92049,172,6181.07129,825,70829-apr-24CEUX305,73515.91234,864,9471.07125,211,33129-apr-24TQEX57,67915.9151917,9671.0712983,32629-apr-24AQEU30,95515.9084492,4451.0712527,507970,52415.917115,447,97716,547,873 As of April 29, 2024, the Company held in treasury 34,146,305 ordinary shares (including 17,779,302 ordinary shares bought in the first tranche), equal to 2.89%
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 202430.4.2024 22:01:00 CEST | Press release
Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held on 30 April 2024 were approved. The AGM approved, amongst other items: The Remuneration Report and revised Remuneration PolicyThe remuneration of the members of the Board of DirectorsThe reappointment of Dr. Elisabeth Svanberg as Independent Non-Executive Director The appointments of Dr. Susanne Schaffert and Mr. Simon Sturge as Independent Non-Executive Directors and Mr. Andrew Dickinson as Non-Executive Director The charging of the statutory auditor with respect to the “assurance” of the CSRD sustainability reporting The EGM approved, amongst other items: The issuance of the Subsequent Gilead Warrant B The renewal of the company’s authorized capital by up to 20% of the share capital All documents related to the AGM and EGM can be consulted on our website. The minutes of the
Eavor Partners with the Government of Alberta to Launch the Alberta Drilling Accelerator30.4.2024 22:00:00 CEST | Press release
CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- On April 30, Eavor was joined by Rebecca Schulz, the Minister of Environment & Protected Areas, the Canadian Association of Energy Contractors, the Canadian Geothermal Energy Association, the Rural Municipalities Association, and Brazeau County to commence the planning and development of the Alberta Drilling Accelerator. Led by the Government of Alberta, Eavor, and other stakeholders, the Alberta Drilling Accelerator (ADA) will represent a technology-agnostic, market-driven geothermal test site available for use by any geothermal company to enable novel drilling techniques and off-site technology development. The test bed will be the first of its kind in Canada, firmly establishing Alberta as a global leader in geothermal technology commercialization and exports. Additionally, the ADA will help ensure the province keeps pace with other government-supported geothermal test sites, such as Utah FORGE in the United States, the Continenta